Drugmaker shares rally on US cancer ruling over Zantac
Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.
Dec 7, 2022
0
5
Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.
Dec 7, 2022
0
5
A campaign to vaccinate the elderly has sparked hopes China might roll back severe anti-virus controls that prompted protesters to demand President Xi Jinping resign, but the country faces daunting hurdles and up to a year ...
Nov 30, 2022
0
0
China announced the relaxation of some of its hardline COVID-19 restrictions on Friday, a day after authorities had vowed to stick to a zero-tolerance virus approach despite mounting economic damage.
Nov 11, 2022
0
20
Although asthma is one of the most common respiratory conditions for children, kids don't always carry their inhalers, or may not even know they have asthma. State legislatures have implemented stock inhaler programs to ensure ...
Nov 10, 2022
0
0
Chinese health officials gave no indication Saturday of any relaxation of COVID-19 restrictions, following several days of speculation that the government was considering changes to a "zero-COVID" approach that has stymied ...
Nov 6, 2022
0
8
Most developed countries hold significant quantities of medical supplies in reserve to respond in an emergency.
Oct 24, 2022
0
2
Bright Health Group will end individual and family health insurance coverage and reduce its Medicare Advantage coverage to just two states, steps that will cut its revenue in half.
Oct 13, 2022
0
23
British health officials on Wednesday warned that non-urgent hospital operations could be cancelled due to a shortage in blood stocks, calling for more supplies.
Oct 12, 2022
0
2
Chinese drug regulators have approved the world's first inhalable COVID-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company's share price by seven percent on Monday.
Sep 5, 2022
0
32
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4